AXIS 发表于 2025-3-23 10:41:06

Submitted on: 25 September 2024.
Revised on: 27 October 2024.
Accepted on: 10 November 2024.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

mutineer 发表于 2025-3-23 13:54:01

Submitted on: 22 December 2022.
Revised on: 18 February 2023.
Accepted on: 14 April 2023.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

确定 发表于 2025-3-23 21:06:00

Submitted on: 07 July 1998.
Revised on: 05 August 1998.
Accepted on: 03 October 1998.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

CRUMB 发表于 2025-3-23 22:20:09

Submitted on: 17 October 2004.
Revised on: 27 January 2005.
Accepted on: 14 March 2005.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

纤细 发表于 2025-3-24 05:30:44

Submitted on: 11 July 2021.
Revised on: 04 November 2021.
Accepted on: 09 December 2021.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

Negligible 发表于 2025-3-24 08:29:16

http://reply.papertrans.cn/2/104/10347/10347-16.png

arousal 发表于 2025-3-24 14:36:30

http://reply.papertrans.cn/2/104/10347/10347-17.png

grandiose 发表于 2025-3-24 16:11:39

Submitted on: 11 February 2016.
Revised on: 04 March 2016.
Accepted on: 14 April 2016.

___________________GaBI Journal-Generics and Biosimilars Initiative Journal

Visual-Field 发表于 2025-3-24 19:57:37

http://reply.papertrans.cn/2/104/10347/10347-19.png

凝结剂 发表于 2025-3-25 01:34:09

http://reply.papertrans.cn/2/104/10347/10347-20.png
页: 1 [2] 3 4
查看完整版本: ESCI期刊GaBI Journal-Generics and Biosimilars Initiative Journal 2024/2025影响因子:0.345 (GABI J) (2033-6403). (PHARMACOLOGY